TrialBone marrow transplantation2016

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT.

W I Bensinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.